Company profile for Naveris

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Naveris has developed highly sensitive blood tests for cancers to enable early diagnosis in the general asymptomatic population, real-time monitoring of response in patients undergoing treatment, and detection of cancer recurrence in patients in remission. Our tests use disruptive proprietary technology to capture and analyze cancer-associated DNA in blood plasma that has increased sensitivity compared to existing circulatin...
Naveris has developed highly sensitive blood tests for cancers to enable early diagnosis in the general asymptomatic population, real-time monitoring of response in patients undergoing treatment, and detection of cancer recurrence in patients in remission. Our tests use disruptive proprietary technology to capture and analyze cancer-associated DNA in blood plasma that has increased sensitivity compared to existing circulating tumor DNA tests.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
22 Strathmore Road Natick, MA 01760
Telephone
Telephone
(833)-628-3747
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

IPhEB Russia

Not Confirmed

envelop Contact Supplier

IPhEB Russia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20260109393252/en/Naveris-to-Highlight-New-Publications-at-the-44th-Annual-J.P.-Morgan-Healthcare-Conference

BUSINESSWIRE
09 Jan 2026

https://www.businesswire.com/news/home/20251117164764/en/Naveris-Announces-Expanded-Medicare-Coverage-for-the-NavDx-Test-in-Identification-of-Molecular-Residual-Disease-of-Anal-Squamous-Cell-Carcinoma

BUSINESSWIRE
17 Nov 2025

https://www.businesswire.com/news/home/20240529938817/en

BUSINESSWIRE
29 May 2024

https://www.businesswire.com/news/home/20240314262635/en

BUSINESSWIRE
14 Mar 2024

https://www.businesswire.com/news/home/20230412005097/en

BUSINESSWIRE
12 Apr 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty